StockNews.com assumed coverage on shares of Steel Partners (NYSE:SPLP – Free Report) in a research note released on Sunday. The firm issued a strong-buy rating on the conglomerate’s stock.
Steel Partners Stock Performance
NYSE SPLP opened at $40.95 on Friday. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.15 and a current ratio of 1.26. Steel Partners has a fifty-two week low of $33.12 and a fifty-two week high of $43.70. The stock has a market cap of $834.97 million, a P/E ratio of 6.00 and a beta of 1.35. The stock has a 50 day simple moving average of $39.05 and a two-hundred day simple moving average of $38.23.
Steel Partners (NYSE:SPLP – Get Free Report) last released its quarterly earnings results on Wednesday, August 7th. The conglomerate reported $4.85 earnings per share for the quarter. Steel Partners had a net margin of 11.04% and a return on equity of 21.44%. The business had revenue of $533.16 million for the quarter.
Institutional Trading of Steel Partners
Steel Partners Company Profile
Steel Partners Holdings L.P., together with its subsidiaries, engages in industrial products, energy, banking, defense, supply chain management, logistics, and youth sports businesses worldwide. It operates through Diversified Industrial, Energy, Financial Services, and Supply Chain segments. The company fabricates precious metals and alloys into brazing alloys; manufactures and sells seamless stainless steel tubing coils; fasteners, adhesives, and fastening systems for the commercial low slope roofing industry, as well as specialty fasteners for the building products industry; and woven substrates of fiberglass, quartz, carbon, and aramid materials for specialty applications.
See Also
- Five stocks we like better than Steel Partners
- What Are the U.K. Market Holidays? How to Invest and Trade
- Why Lennar Stock Could Be the Best Play in the Housing Market
- The Significance of Brokerage Rankings in Stock Selection
- 2 Energy Stocks Fueling the AI Datacenter Boom
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Steel Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steel Partners and related companies with MarketBeat.com's FREE daily email newsletter.